News + Filings Holdings
All
13F
13D/G
Other
|
|
GV 2017, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/08/2022 |
4
| GV 2017 GP, L.L.C. (Member of 10% Group) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Disposed of 48,583 shares
@ $0
Sold 47,690 shares
@ $31.118, valued at
$1.5M
Sold 651 shares
@ $31.9905, valued at
$20.8k
Sold 242 shares
@ $32.9, valued at
$8k
Sold 47,690 shares
@ $31.118, valued at
$1.5M
Sold 650 shares
@ $31.9905, valued at
$20.8k
Sold 243 shares
@ $32.9, valued at
$8k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| GV 2017 GP, L.L.C. (10% Owner) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Converted 6,320,905 shares
@ $0
Converted 58,528,428 preferred shares
@ $0 |
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2018 |
4
| GV 2017 GP, L.L.C. (10% Owner) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Converted 1,924,474 shares
@ $0
Converted 1,924,474 convertible preferred
@ $0 |
|
|
|